FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma

FTY720 is an immunosuppressant developed to prevent organ transplant rejection. Recent studies indicate an additional role for FTY720 in inducing cell apoptosis. We demonstrate here that FTY720 mediates toxic effects in cell lines representing different B-cell malignancies and primary B cells from p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Liu, Qing, Zhao, Xiaobin, Frissora, Frank, Ma, Yihui, Santhanam, Ramasamy, Jarjoura, David, Lehman, Amy, Perrotti, Danilo, Chen, Ching-Shih, Dalton, James T., Muthusamy, Natarajan, Byrd, John C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2008
Assuntos:
Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2200813/
https://ncbi.nlm.nih.gov/pubmed/17761520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-10-053884
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados